Metabolic remodeling in the hypertrophic heart: Fuel for thought

Circulation Research

Volumn 111, Issue 6, 2012, Pages 666-668

  Chatham, John C ^a   Young, Martin E ^b  

^a Department of Pathology   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

bioenergetics; cardiac metabolism; fatty acids; heart; heart contractility; hypertrophy

Indexed keywords

ACETYL COENZYME A; DIACYLGLYCEROL; HEXOSAMINE; PHOSPHOLIPID;

FATTY ACID METABOLISM; HEART FAILURE; HEART HYPERTROPHY; METABOLISM; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; TISSUE REGENERATION;

ACETYL-COA CARBOXYLASE; ANIMALS; CARDIOMEGALY; FEMALE; MALE; MYOCARDIUM; VENTRICULAR REMODELING;

EID: 84865847066     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.112.277392     Document Type: Review

References (26)

1. Taegtmeyer H. Metabolism: the lost child of cardiology. J Am Coll Cardiol. 2000;36:1386-1388.
2. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010; 90:207-258.
3. Allard M, Schonekess B, Henning S, English D, Lopaschuk G. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol. 1994;267:H742-H750.
4. Abel E, Litwin S, Sweeney G. Cardiac remodeling in obesity. Physiol Rev. 2008;88:389-419.
5. Taegtmeyer H, McNulty P, Young ME. Adaptation and maladaptation of the heart in diabetes: part I: general concepts. Circulation. 2002;105: 1727-1733.
6. Larsen TS, Aasum E. Metabolic (in)flexibility of the diabetic heart. Cardiovasc Drugs Ther. 2008;22:91-95.
7. Lopaschuk GD, Wambolt RB, Barr RL. An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J Pharmacol Exp Ther. 1993;264:135-144.
8. Taegtmeyer H, Sen S, Vela D. Return to the fetal gene program: a suggested metabolic link to gene expression in the heart. Ann N Y Acad Sci. 2010;1188:191-198.
9. Okere IC, Young ME, McElfresh TA, Chess DJ, Sharov VG, Sabbah HN, Hoit BD, Ernsberger P, Chandler MP, Stanley WC. Low carbohydrate/high-fat diet attenuates cardiac hypertrophy, remodeling, and altered gene expression in hypertension. Hypertension. 2006;48:1116-1123.
10. Berthiaume JM, Young ME, Chen X, McElfresh TA, Yu X, Chandler MP. Normalizing the metabolic phenotype after myocardial infarction: impact of subchronic high fat feeding. J Mol Cell Cardiol. 2012;53: 125-133.
11. Young M, Laws F, Goodwin G, Taegtmeyer H. Reactivation of peroxisome proliferator-activated receptor-is associated with contractile dysfunction in hypertrophied rat heart. J Biol Chem. 2001;276: 44390-44395.
12. Kolwicz SC, Olson DP, Marney LC, Garcia-Menendez L, Synovec RE, Tian R. Cardiac-specific deletion of acetyl CoA carboxylase 2 (ACC2) prevents metabolic remodeling during pressure-overload hypertrophy. Circ Res. 2012;111:728-738.
13. Neubauer S. The failing heart: an engine out of fuel. N Engl J Med. 2007;356:1140-1151.
14. Ingwall JS. Energy metabolism in heart failure and remodelling. Cardiovasc Res. 2009;81:412-419.
15. McClain DA. Hexosamines as mediators of nutrient sensing and regulation in diabetes. J Diabetes Complications. 2002;16:72-80.
16. Hanover JA, Krause MW, Love DC. The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. Biochim Biophys Acta. 2010;1800: 80-95.
17. Hart GW, Slawson C, Ramirez-Correa G, Lagerlof O. Cross Talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem. 2011;80:825-858.
18. Darley-Usmar VM, Ball LE, Chatham JC. Protein O-linked beta-Nacetylglucosamine: a novel effector of cardiomyocyte metabolism and function. J Mol Cell Cardiol. 2012;52:538-549.
19. Chatham JC, Marchase RB. The role of protein O-linked beta-Nacetylglucosamine in mediating cardiac stress responses. Biochim Biophys Acta. 2010;1800:57-66.
20. Porter K, Medford HM, McIntosh CM, Marsh SA. Cardioprotection requires flipping the "posttranslational modification" switch. Life Sci. 2012;90:89-98.
21. Young ME, Yan J, Razeghi P, Cooksey RC, Guthrie PH, Stepkowski SM, McClain DA, Tian R, Taegtmeyer H. Proposed regulation of gene expression by glucose in rodent heart. Gene Regul Syst Bio. 2007;1: 251-262.
22. Watson LJ, Facundo HT, Ngoh GA, Ameen M, Brainard RE, Lemma KM, Long BW, Prabhu SD, Xuan YT, Jones SP. O-linked beta-Nacetylglucosamine transferase is indispensable in the failing heart. Proc Natl Acad Sci USA. 2010;107:17797- 17802.
23. Facundo HT, Brainard RE, Watson LJ, Ngoh GA, Hamid T, Prabhu SD, Jones SP. O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy. Am J Physiol Heart Circ Physiol. 2012;302:H2122-H2130.
24. Liao R, Jain M, Cui L, D'Agostino J, Aiello F, Luptak I, Ngoy S, Mortensen RM, Tian R. Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice. Circulation. 2002;106:2125-2131.
25. Young M, McNulty P, Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes: part II: potential mechanisms. Circulation. 2002; 105:1861-1870.
26. Chien AJ, Hosey MM. Post-translational modifications of beta subunits of voltage-dependent calcium channels. J Bioenerg Biomembr. 1998;30:377-386.